Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |